The future role of gut hormones in the treatment of obesity (Q30357431)

20 August 2017

The future role of gut hormones in the treatment of obesity (English)

1 reference

ORCID Public Data File 2021

20 August 2017

0 references

1 reference

author name string

Rachel C Troke

series ordinal

1 reference

20 August 2017

Tricia M Tan

series ordinal

1 reference

20 August 2017

Steve R Bloom

series ordinal

1 reference

20 August 2017

1 January 2014

1 reference

Therapeutic advances in chronic disease

20 August 2017

1 reference

20 August 2017

1 reference

20 August 2017

1 reference

20 August 2017

4-14

1 reference

A critical analysis of the clinical use of incretin-based therapies: Are the GLP-1 therapies safe?

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

A critical analysis of the clinical use of incretin-based therapies: The benefits by far outweigh the potential risks

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Physiologic concentrations of exogenously infused ghrelin reduces insulin secretion without affecting insulin sensitivity in healthy humans

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Comparison of postprandial profiles of ghrelin, active GLP-1, and total PYY to meals varying in fat and carbohydrate and their association with hunger and the phases of satiety

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Coadministration of glucagon-like peptide-1 during glucagon infusion in humans results in increased energy expenditure and amelioration of hyperglycemia

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

GOAT induced ghrelin acylation regulates hedonic feeding

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Human pancreatic polypeptide in a phospholipid-based micellar formulation

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Salivary PYY: a putative bypass to satiety

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Liraglutide: clinical pharmacology and considerations for therapy

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Pharmacokinetics, adverse effects and tolerability of a novel analogue of human pancreatic polypeptide, PP 1420.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Long-acting lipidated analogue of human pancreatic polypeptide is slowly released into circulation

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Changes in Gastrointestinal Hormones and Leptin After Roux‐en‐Y Gastric Bypass Surgery

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Peripheral glucagon-like peptide-1 (GLP-1) and satiation

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Association between body-mass index and risk of death in more than 1 million Asians

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Rise of oxyntomodulin in response to oral glucose after gastric bypass surgery in patients with type 2 diabetes

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

PYY3-36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humans.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Critical role of arcuate Y4 receptors and the melanocortin system in pancreatic polypeptide-induced reduction in food intake in mice

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

A review of exenatide as adjunctive therapy in patients with type 2 diabetes

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Lean mean fat reducing "ghrelin" machine: hypothalamic ghrelin and ghrelin receptors as therapeutic targets in obesity

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Surgical approaches to the treatment of obesity: bariatric surgery

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Inhibition of ghrelin O-acyltransferase (GOAT) by octanoylated pentapeptides.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Introducing GOAT: a target for obesity and anti-diabetic drugs?

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Gastric distention activates satiety circuitry in the human brain

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Long term pharmacotherapy for obesity and overweight: updated meta-analysis.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Critical role for peptide YY in protein-mediated satiation and body-weight regulation

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Vaccination against weight gain

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Ghrelin neutralization by a ribonucleic acid-SPM ameliorates obesity in diet-induced obese mice

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Vagotomy dissociates short- and long-term controls of circulating ghrelin

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Inhibition of food intake in obese subjects by peptide YY3-36

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Pancreatic polypeptide reduces appetite and food intake in humans

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Antagonism of ghrelin receptor reduces food intake and body weight gain in mice

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Characterization of the effects of pancreatic polypeptide in the regulation of energy balance

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Gut hormone PYY(3-36) physiologically inhibits food intake

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion

3 June 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

3 June 2018

https://api.crossref.org/works/10.1177%2F2040622313506730

Regional distribution of Y-receptor subtype mRNAs in rat brain

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Complete sequences of glucagon-like peptide-1 from human and pig small intestine

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

[Cellular localization, half-life, and secretion of peptide YY]

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Oxyntomodulin from distal gut. Role in regulation of gastric and pancreatic functions

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Distribution and release of human pancreatic polypeptide

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Pharmacokinetics of pancreatic polypeptide in man

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3871274

Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety.

3 June 2018

1 reference

https://api.crossref.org/works/10.1177%2F2040622313506730

Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2040622313506730

Peripheral oxyntomodulin reduces food intake and body weight gain in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2040622313506730

Repeated ICV administration of oxyntomodulin causes a greater reduction in body weight gain than in pair-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2040622313506730

A new glucagon and GLP-1 co-agonist eliminates obesity in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2040622313506730

Effect of macronutrient composition on postprandial peptide YY levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2040622313506730

Efficacy and safety of intranasal peptide YY3-36 for weight reduction in obese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2040622313506730

Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2040622313506730

Identification of ghrelin and its receptor in neurons of the rat arcuate nucleus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2040622313506730

Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2040622313506730

Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2040622313506730

A role for pancreatic polypeptide in the regulation of gastric emptying and short-term metabolic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2040622313506730

Reversible PEGylation of peptide YY3-36 prolongs its inhibition of food intake in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2040622313506730

Oral administration of glucagon-like peptide 1 or peptide YY 3-36 affects food intake in healthy male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2040622313506730

Longer acting GLP-1 receptor agonists and the potential for improved cardiovascular outcomes: a review of current literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2040622313506730

Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2040622313506730

Immunohistochemical localization of human pancreatic polypeptide (HPP) to a population of islet cells

21 January 2018

1 reference

12 December 2020

Oxyntomodulin suppresses appetite and reduces food intake in humans

1 reference

12 December 2020

The gut hormone response following Roux-en-Y gastric bypass: cross-sectional and prospective study

1 reference

12 December 2020

Ghrelin increases food intake in obese as well as lean subjects

1 reference

12 December 2020

Peptide YY3-36 and pancreatic polypeptide suppress food intake

1 reference

12 December 2020

Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat

1 reference

12 December 2020

Underweight, overweight and obesity as risk factors for mortality and hospitalization

1 reference

12 December 2020

Low-dose pancreatic polypeptide inhibits food intake in man

1 reference

12 December 2020

Subcutaneous administration of ghrelin stimulates energy intake in healthy lean human volunteers

1 reference

12 December 2020

Reduced pancreatic polypeptide secretion in obese subjects

1 reference

12 December 2020

Oxyntomodulin inhibits food intake in the rat

1 reference

12 December 2020

Pancreatic polypeptide infusions reduce food intake in Prader-Willi syndrome

1 reference

12 December 2020

No evidence of an additive inhibitory feeding effect following PP and PYY3−36 administration

1 reference

12 December 2020

Oral delivery of the appetite suppressing peptide hPYY(3-36) through the vitamin B12 uptake pathway

1 reference

12 December 2020

Identifiers

DOI

10.1177/2040622313506730

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

24381724

1 reference